2-amino-5-phosphonovalerate has been researched along with sevoflurane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, M; Masaki, E; Matsumoto, Y; Nishi, H; Ohno, Y; Yamazaki, K | 1 |
| Hirota, K; Roth, SH; Sasaki, R; Yamazaki, M | 1 |
| Arendt-Nielsen, L; Sumikura, H | 1 |
3 other study(ies) available for 2-amino-5-phosphonovalerate and sevoflurane
| Article | Year |
|---|---|
The anesthetic interaction between adenosine triphosphate and N-methyl-D-aspartate receptor antagonists in the rat.
Topics: 2-Amino-5-phosphonovalerate; Anesthetics, Inhalation; Animals; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Injections, Intraventricular; Male; Methyl Ethers; Pulmonary Alveoli; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sevoflurane; Stereoisomerism | 2001 |
Extracellular magnesium ion modifies the actions of volatile anesthetics in area CA1 of rat hippocampus in vitro.
Topics: 2-Amino-5-phosphonovalerate; Anesthetics, Inhalation; Animals; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Isoflurane; Magnesium; Male; Membrane Potentials; Methyl Ethers; Pyramidal Cells; Rats; Rats, Wistar; Sevoflurane | 2002 |
MAC reduction after intrathecal coadministration of GABA(A) agonist and glutamate antagonist in rats.
Topics: 2-Amino-5-phosphonovalerate; Anesthetics, Inhalation; Animals; Drug Synergism; Excitatory Amino Acid Antagonists; GABA Agonists; Imidazoles; Injections, Spinal; Male; Methyl Ethers; Muscimol; N-Methylaspartate; Pain; Pulmonary Alveoli; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Sevoflurane | 2003 |